Becton Dickinson (BDX) Tops Q1 EPS by 2c, Revenues Beat; Lowers FY20 EPS Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. LYB
6. TFII
7. LITE
8. NVT
9. SPY
10. RELIANCE:I

Go back to Becton Dickinson (BDX) Tops Q1 EPS by 2c, Revenues Beat; Lowers FY20 EPS Guidance Below Consensus

BD Announces Results For 2020 First Fiscal Quarter; Lowers Fiscal 2020 Guidance

February 6, 2020 6:00 AM EST

FRANKLIN LAKES, N.J., Feb. 6, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.225 billion for the first fiscal quarter ended December 31, 2019.  This represents an increase of 1.6 percent as reported over the prior-year period, or 2.5 percent on a currency-neutral basis.

BD also announced today that it is continuing to work with the U.S. Federal Drug Administration (FDA) on its software remediation plan for the Alaris System, which will require additional regulatory filings beyond what the company previously anticipated.... More